Denmark· DK-28101699994
Cerubidine
A daunorubicin product containing daunorubicinhydrochlorid, registered in Denmark by Orifarm A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Daunorubicin is registered in 13 of 19 countries.
Countries holding a registration under ATC L01DB02 (daunorubicin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Daunorubicin · ATC L01DB02
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- DAUNORUBICINHYDROCHLORID
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- L01DB02
- ATC class
- Daunorubicin
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101699994
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
440 interactions on record for daunorubicin.
Graded by severity as the source publishes them — 98 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Daunorubicin · interactions on record
440 records
- 98 severe
- 332 moderate
- 10 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01DB02
Daunorubicin, as other registers publish it.
- FinlandCerubidinRhone-Poulenc Rorer A/S
- NorwayCerubidinSanofi-aventis Norge (3)
- IrelandCerubidin 20 mg Powder for Concentrate for Solution for InfusionSanofi-Aventis Ireland Limited T/A SANOFI
- CanadaCERUBIDINESEARCHLIGHT PHARMA INC
- BelgiumCerubidine 20 mgSanofi Belgium
- FranceCERUBIDINE 20 mg, poudre pour solution pour perfusionSANOFI WINTHROP INDUSTRIE
- NetherlandsCerubidine 20mg, poeder en oplosmiddel voor oplossing voor injectieSanofi B.V.
- GermanyDaunoblastinPfizer Pharma Gmbh
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f05f639f-e0b8-49b0-9260-8ee98b623841 GET /v1/drugs/f05f639f-e0b8-49b0-9260-8ee98b623841?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til infusionsvæske, opløsning",
"source": "dkma",
"strength": "20 mg",
"auth_role": "DKMA",
"dk_drugid": "28101699994",
"substance": "DAUNORUBICINHYDROCHLORID",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "34920"
}See everything about daunorubicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.